Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Synthekine
AddedFeb 13, 2024
UpdatedJun 18, 2026
Synthekine

Synthekine

Series C

US-based Synthekine engineers cytokines to develop transformative treatments for cancer and autoimmune disorders.

HQ
Menlo Park, CA, US
Founded
2018
Overview
Compare
Fundraising
Employees
Website

Founded in Menlo Park, United States, Synthekine is dedicated to developing disease-optimized treatments through engineered cytokine therapeutics. The company's core mission is to harness immunological insights to guide targeted protein engineering, creating transformative medicines for cancer and autoimmune disorders. Synthekine focuses on discovering, developing, and commercializing the next generation of selective cytokine therapeutics to address unmet medical needs in these markets.

Synthekine has attracted notable investors and affiliations with leading experts in immunology and biotechnology. The company has achieved significant milestones, including advancing its proprietary cytokine engineering platform and initiating clinical trials for its lead candidates. Synthekine's innovative approach has the potential to significantly impact the treatment landscape for cancer and autoimmune diseases, offering new hope for patients with these challenging conditions.

Synthekine - Similar Companies

Kyverna Therapeutics logo

Kyverna Therapeutics

Deka Biosciences logo

Deka Biosciences

Simcha Therapeutics logo

Simcha Therapeutics

simchatx.com

ImmunGene logo

ImmunGene

AskGene Pharma logo

AskGene Pharma

MacroGenics logo

MacroGenics

macrogenics.com

Synkrino Biotherapeutics logo

Synkrino Biotherapeutics

synkrino.bio

Eikon Therapeutics logo

Eikon Therapeutics

eikontx.com

Celsius Therapeutics logo

Celsius Therapeutics

celsiustx.com

HI-Bio logo

HI-Bio

hibio.com

Cel-Sci logo

Cel-Sci

cel-sci.com

Siren Biotechnology logo

Siren Biotechnology

Cue Biopharma logo

Cue Biopharma

Ernexa Therapeutics logo

Ernexa Therapeutics

eternatx.com

Synedgen logo

Synedgen

synedgen.com

Synthekine - Quick Facts

Who are Synthekine's competitors?

Companies similar to Synthekine include Kyverna Therapeutics, Deka Biosciences, Simcha Therapeutics and ImmunGene.

When was Synthekine founded?

Synthekine was founded in 2018.

Where is Synthekine's headquarters located?

Synthekine's headquarters is located in Menlo Park, CA, US.

When was Synthekine's last funding round?

Synthekine's most recent funding round was for $100M (USD) in January 2023.

How much has Synthekine raised to-date?

As of Jan 6, 2023, Synthekine has raised a total of $289.5M (USD).

How many employees does Synthekine have?

Synthekine has 122 employees as of Feb 4, 2024.

Synthekine - Classification

Ownership
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Therapeutics
  • Treatments
Tags
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 13 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 8000Health Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified